Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: Regulation of synovial proliferation and inflammatory gene expression

Arthritis and Rheumatism

Volumn 54, Issue 3, 2006, Pages 742-753

  Kitano, Masayasu ^a   Hla, Timothy ^b   Sekiguchi, Masahiro ^a   Kawahito, Yutaka ^c   Yoshimura, Rikio ^d   Miyazawa, Keiji ^e   Iwasaki, Tsuyoshi ^a   Sano, Hajime ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e Kissei Pharmaceutical   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; PERTUSSIS TOXIN; PROSTAGLANDIN E2; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CELL PROLIFERATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MONONUCLEAR CELL; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE; SYNOVIUM; TISSUE LEVEL; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; CELL LINE; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYSOPHOSPHOLIPIDS; MEMBRANE PROTEINS; OSTEOARTHRITIS; PERTUSSIS TOXIN; RECEPTORS, LYSOSPHINGOLIPID; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPHINGOSINE; SYNOVIAL MEMBRANE; TISSUE CULTURE TECHNIQUES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644880217     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21668     Document Type: Article

References (48)

1. Sanchez T, Hla T. Structural and functional characteristics of S1P receptors. J Cell Biochem 2004;92:913-22.
2. Hla T. Signaling and biological actions of sphingosine 1-phosphate. Pharmacol Res 2003;47:401-7.
3. Hla T. Physiological and pathological actions of sphingosine-1-phosphate. Semin Cell Dev Biol 2004;15:513-20.
4. Yatomi Y, Ruan F, Hakomori S, Igarashi Y. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 1995;86:193-202.
5. Yang L, Yatomi Y, Miura Y, Satoh K, Ozaki Y. Metabolism and functional effects of sphingolipids in blood cells. Br J Haematol 1999;107:282-93.
6. Ancellin N, Colmont C, Su J, Li Q, Mittereder N, Chae SS, et al. Extracellular export of sphingosine kinase-1 enzyme: sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. J Biol Chem 2002;277:6667-75.
7. Julien D, Cyrille G, Aida H, Liying L, Ariane M, Jiangchuan T, et al. Antiproliferative properties of sphingosine 1-phosphate in human hepatic myofibroblasts. J Biol Chem 2000;275:34628-33.
8. Kim JI, Jo EJ, Lee HY, Cha MS, Min JK, Choi CH, et al. Sphingosine 1-phosphate in amniotic fluid modulates cyclooxygenase-2 expression in human amnion-derived WISH cells. J Biol Chem 2003;278:31731-6.
9. Pettus BJ, Bielawski J, Porcelli AM, Reames DL, Johnson KR, Morrow J, et al. The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNFα. FASEB J 2003;17:1411-20.
10. Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA. Detection of tumor necrosis factor a but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988;31:1041-4.
11. Eastgate JA, Wood NC, Digiovine FS, Symons JA, Grinlinton FM, Duff GW. Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis. Lancet 1988;2:706-9.
12. Olsen NJ, Stein CB. New drugs for rheumatoid arthritis. N Engl J Med 2004;20:2167-79.
13. Crofford LJ, Wilder RL, Ristimaki AP, Sano H, Remmers RF, Epps HR, et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: effects of interleukin-1β, phorbol ester, and corticosteroids. J Clin Invest 1994;93:1095-101.
14. Kojima F, Naraba H, Sasaki Y, Okamoto R, Koshino T, Kawai S. Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells. J Rheumatol 2002;29:1836-42.
15. Elliott MJ, Maini RN, Feldmann M. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 1994;344:1105-10.
16. Den Broeder A, van de Putte LB. A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-α antibody adalimumab (D2E7) in patients with rheumatoid arthritis. J Rheumatol 2002;29:2288-98.
17. Moreland LW, Baumgartner SW, Schiff MH. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997;337:141-7.
18. Fleischmann RM, Schechtman J, Bennett R, Handel ML, Burmester GR, Tesser J, et al, for the 990757 Study Group. Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: a large, international, multicenter, placebo-controlled trial. Arthritis Rheum 2003;48:927-34.
19. O'Neill GP, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 1993;330:156-60.
20. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A 1992;89:7384-8.
21. Sano H, Hla T, Maier JA, Crofford LJ, Case JP, Maciag T, et al. In vitro cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest 1992;89:97-108.
22. Ben-Av P, Crofford LJ, Wilder RL, Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 1995;372:83-7.
23. 2-dependent production of interleukin-11 in rheumatoid synovial fibroblasts. Arthritis Rheum 1998;42:2004-13.
24. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1998;31:315-24.
25. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
26. Miyazawa K, Mori A, Okudaira H. Establishment and characterization of a novel human rheumatoid fibroblast-like synoviocyte line, MH7A, immortalized with SV40T antigen. J Biochem 1998;124:1153-62.
27. 2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest 2000;106:189-97.
28. Andre-Garnier E, Robillard N, Costa-Mattioli M, Besse B, Billaudel S, Imbert-Marcille BM. A one-step RT-PCR and a flow cytometry method as two specific tools for direct evaluation of human herpesvirus-6 replication. J Virol Methods 2003;108:213-22.
29. Lee MJ, Thangada S, Paik JH, Sapkota GP, Ancellin N, Chae SS, et al. Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Mol Cell 2001;8:693-704.
30. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995;55:3785-9.
31. Yoshimura Y, Sano H, Masuda C, Kawamura M, Tsubouchi Y, Chargui J, et al. Expression of cyclooxygenase-2 in prostate carcinoma. Cancer 2000;89:589-96.
32. Sano H, Engleka K, Mathern P, Hla T, Crofford JL, Remmers EC, et al. Coexpression of phosphotyrosine-containing proteins, platelet-derived growth factor-B, and fibroblast growth factor-1 in situ in synovial tissues of patients with rheumatoid arthritis and Lewis rats with adjuvant or streptococcal cell wall arthritis. J Clin Invest 1993;91:553-65.
33. 2. Biochem Biophys Res Commun 2001;283:750-5.
34. Paik JH, Chae S, Lee MJ, Thangada S, Hla T. Sphingosine-1-phosphate- induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and rho-dependent activation of αvβ- and β1-containing integrins. J Biol Chem 2001;276:11830-7.
35. Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, Kluk MJ. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 1999;99:301-12.
36. Hla T, Lee MJ, Ancellin N, Paik JH, Kluk MJ. Lysophospholipids: receptor revelations. Science 2001;294:1875-8.
37. Graeler M, Goetzl EJ. Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells. FASEB J 2002;16:1874-8.
38. Lee H, Liao JJ, Graeler M, Huang MC, Goetzl EJ. Lysophospholipid regulation of mononuclear phagocytes. Biochim Biophys Acta 2002;1582:175-7.
39. Goetzl EJ, Rosen H. Regulation of immunity by lysosphingolipids and their G protein-coupled receptors. J Clin Invest 2004;114:1531-7.
40. Cuvillier O, Levade T. Enzymes of sphingosine metabolism as potential pharmacological targets for therapeutic intervention in cancer. Pharmacol Res 2003;47:439-45.
41. Perry DK, Kolesnick RN. Ceramide and sphingosine 1-phosphate in anti-cancer therapies. Cancer Treat Res 2003;115:345-54.
42. Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, Hobson JP. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 2000;106:951-61.
43. Hla T. Sphingosine 1-phosphate receptors. Prostaglandins 2001;64:135-42.
44. 44: Lee MJ, van Brocklyn JR, Thangada S, Liu CH, Hand AR, Menzeleev R, et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 1998;279:1552-5.
45. Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signaling lipid. Nat Rev Mol Cell Biol 2003;4:397-407.
46. Lee SS, Joo YS, Kim WU, Min JK, Park SH, Cho CS, et al. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 2001;19:321-4.
47. Jackson JR, Minton JA, Ho ML, Wei N, Winkler JD. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1β. J Rheumatol 1997;24:1253-9.
48. Hayakawa M, Jayadev S, Tsujimoto M, Hannun YA, Ito F. Role of ceramide in stimulation of the transcription of cytosolic phospholipase A2 and cyclooxygenase 2. Biochem Biophys Res Commun 1996;220:681-6.